{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T13:15:58Z","timestamp":1698844558669},"reference-count":27,"publisher":"Akademiai Kiado Zrt.","issue":"24","license":[{"start":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T00:00:00Z","timestamp":1623542400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2021,6,13]]},"abstract":"<jats:p><jats:bold>\u00d6sszefoglal\u00f3.<\/jats:bold>\n                    <jats:italic>Bevezet\u00e9s:<\/jats:italic> Az endovascularis intervenci\u00f3kat kezdetben\n                    radiol\u00f3gusok alkalmazt\u00e1k, manaps\u00e1g, megfelel\u0151 k\u00e9pz\u00e9st k\u00f6vet\u0151en, j\u00f3 eredm\u00e9nnyel\n                    v\u00e9geznek ilyen beavatkoz\u00e1sokat \u00e9rseb\u00e9szek is. Ezt a vil\u00e1gszerte uralkod\u00f3v\u00e1 v\u00e1l\u00f3\n                    szeml\u00e9letet k\u00edv\u00e1ntuk meghonos\u00edtani a Szegedi Tudom\u00e1nyegyetemen, melynek\n                    bevezet\u00e9se n\u00e9lk\u00fcl el\u0151revet\u00edthet\u0151 az \u00e9rseb\u00e9szet m\u0171k\u00f6d\u00e9s\u00e9nek \u00e1talakul\u00e1sa az\n                    \u00e9rrekonstrukci\u00f3s beavatkoz\u00e1sok cs\u00f6kken\u00e9s\u00e9vel. <jats:italic>C\u00e9lkit\u0171z\u00e9s:<\/jats:italic>\n                    Egyetem\u00fcnk\u00f6n radiol\u00f3gus- \u00e9s \u00e9rseb\u00e9sz-munkacsoport v\u00e9gez perif\u00e9ri\u00e1s\n                    \u00e9rintervenci\u00f3kat. C\u00e9lunk a k\u00e9t int\u00e9zet als\u00f3 v\u00e9gtagi endovascularis\n                    tev\u00e9kenys\u00e9g\u00e9nek \u00f6sszehasonl\u00edt\u00e1sa volt. <jats:italic>M\u00f3dszer:<\/jats:italic> Vizsg\u00e1latunkba\n                    a Szegedi Tudom\u00e1nyegyetemen 2012. 01. 01. \u00e9s 2019. 12. 31. k\u00f6z\u00f6tt als\u00f3 v\u00e9gtagi\n                    endovascularis beavatkoz\u00e1sokon \u00e1tesett betegeket v\u00e1logattuk be. A betegeket a\n                    rizik\u00f3faktoraik, a kezelt anat\u00f3miai r\u00e9gi\u00f3k, a hospitaliz\u00e1ci\u00f3s id\u0151 \u00e9s a\n                    sz\u00f6v\u0151dm\u00e9nyek tekintet\u00e9ben hasonl\u00edtottuk \u00f6ssze. Egy\u00e9ves ut\u00e1nk\u00f6vet\u00e9s sor\u00e1n\n                    vizsg\u00e1ltuk a \u2019redo\u2019 m\u0171t\u00e9tek , az amput\u00e1ci\u00f3k \u00e9s a hal\u00e1loz\u00e1sok gyakoris\u00e1g\u00e1t.\n                        <jats:italic>Eredm\u00e9nyek:<\/jats:italic> A beavatkoz\u00e1sokat 653 esetben radiol\u00f3gus, 573\n                    esetben \u00e9rseb\u00e9sz v\u00e9gezte. Az \u00e9rm\u0171t\u0151ben infrainguinalis (63,2%), a radiol\u00f3gi\u00e1n\n                    suprainguinalis \u00e9rintervenci\u00f3k (68,6%) t\u00f6rt\u00e9ntek nagyobb ar\u00e1nyban. A percutan\n                    v\u00e9gzett beavatkoz\u00e1sokat vizsg\u00e1lva a hospitaliz\u00e1ci\u00f3s id\u0151ben (2,5 \u00b1 4,4 nap vs.\n                    2,4 \u00b1 2,5 nap, p = 0,78), valamint a minim\u00e1lisan invaz\u00edv m\u00f3don v\u00e9gzett\n                    beavatkoz\u00e1sok ut\u00e1ni sz\u00f6v\u0151dm\u00e9nyek gyakoris\u00e1g\u00e1ban (30\/653 \u2013 4,6% \u00e9s 11\/257 \u2013 4,3%,\n                    p = 0,837) nem volt k\u00fcl\u00f6nbs\u00e9g a k\u00e9t betegcsoport k\u00f6z\u00f6tt. \u2019Redo\u2019 m\u0171t\u00e9tek (73\/485\n                    \u2013 15,1% \u00e9s 33\/562 \u2013 5,9%, p&lt;0,001) \u00e9s amput\u00e1ci\u00f3k (31\/485 \u2013 6,4% \u00e9s 12\/562 \u2013\n                    2,1%, p&lt;0,001) gyakrabban fordultak el\u0151 az \u00e9rm\u0171t\u0151ben kezelt betegek k\u00f6r\u00e9ben,\n                    ebben a csoportban azonban a kritikus v\u00e9gtagischaemia el\u0151fordul\u00e1sa is gyakoribb\n                    volt (45,4% \u00e9s 38,6%, p = 0,016). A mortalit\u00e1sban nem volt szignifik\u00e1ns\n                    k\u00fcl\u00f6nbs\u00e9g (5,8% \u00e9s 3,9%, p = 0,16). <jats:italic>K\u00f6vetkeztet\u00e9s:<\/jats:italic> A szoliter\n                    \u00e9relv\u00e1ltoz\u00e1sok kezel\u00e9s\u00e9t mindk\u00e9t int\u00e9zet hasonl\u00f3 hat\u00e1sfokkal v\u00e9gezte. A t\u00f6bb\n                    anat\u00f3miai r\u00e9gi\u00f3t \u00e9rint\u0151 betegs\u00e9g miatt \u00e9rm\u0171t\u0151ben v\u00e9gzett beavatkoz\u00e1sok ut\u00e1ni\n                    sz\u00f6v\u0151dm\u00e9nyek el\u0151fordul\u00e1sa kiss\u00e9 magasabbnak bizonyult. Orv Hetil. 2021; 162(24):\n                    943\u2013951.<\/jats:p>\n                <jats:p><jats:bold>Summary.<\/jats:bold>\n                    <jats:italic>Introduction:<\/jats:italic> Endovascular interventions were initially\n                    performed by radiologists. Nowadays properly trained vascular surgeons also\n                    effectively perform these interventions. We wished to apply this widespread\n                    practice at our university because without this advancement the number of\n                    reconstructive surgeries was expected to decrease significantly.\n                        <jats:italic>Objective:<\/jats:italic> Both radiologists and vascular surgeons perform\n                    endovascular interventions at our university. We compared the outcomes of lower\n                    extremity endovascular interventions between the two institutes.\n                        <jats:italic>Method:<\/jats:italic> We included patients who underwent lower extremity\n                    endovascular interventions between 01. 01. 2012 and 31. 12. 2019. We compared\n                    the risk factors, treated anatomical regions, hospitalization time and\n                    complication rate. During the one-year follow-up, we examined the occurrence of\n                    redo surgeries, amputations and mortality. <jats:italic>Results:<\/jats:italic> 653\n                    interventions were performed by radiologists and 573 by vascular surgeons.\n                    Vascular surgeons carried out more interventions in the infrainguinal region\n                    (63.2%), while radiologists in the suprainguinal region (68.6%). The\n                    hospitalization time after percutaneous interventions (2.5 \u00b1 4.4 days vs. 2.4 \u00b1\n                    2.5 days, p = 0.78), and the rate of complications after minimally invasive\n                    interventions did not show significant difference (30\/653 \u2013 4.6% vs. 11\/257 \u2013\n                    4.3%, p = 0.837). Redo surgeries (73\/485 \u2013 15.1% vs. 33\/562 \u2013 5.9%, p&lt;0.001)\n                    and amputations (31\/485 \u2013 6.4% vs. 12\/562 \u2013 2.1%, p&lt;0.001) occurred more\n                    frequently in the surgical group. However, the incidence of chronic limb\n                    ischaemia was also higher (45.4% vs. 38.6%, p = 0.016). There was no significant\n                    difference in the mortality (5.8% vs. 3.9%, p = 0.16).\n                        <jats:italic>Conclusion:<\/jats:italic> Both institutes had similar efficacy in\n                    performing peripheral interventions on solitary vascular lesions. Complications\n                    occurred more frequently in the surgical group, but the majority of these\n                    patients had extended atherosclerotic diseases. Orv Hetil. 2021; 162(24):\n                    943\u2013951.<\/jats:p>","DOI":"10.1556\/650.2021.32099","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T10:05:43Z","timestamp":1630404343000},"page":"943-951","update-policy":"http:\/\/dx.doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":1,"title":["Szeml\u00e9letv\u00e1ltoz\u00e1s az als\u00f3 v\u00e9gtagi \u00e9rrekonstrukci\u00f3k gyakorlat\u00e1ban a Szegedi Tudom\u00e1nyegyetem \u00c9rseb\u00e9szeti Oszt\u00e1ly\u00e1n"],"prefix":"10.1556","volume":"162","author":[{"given":"Tibor","family":"Tak\u00e1cs","sequence":"first","affiliation":[{"name":"1 Szegedi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szent-Gy\u00f6rgyi Albert Klinikai K\u00f6zpont, Seb\u00e9szeti Klinika, Szeged, Semmelweis u. 8., 6720"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Mihalovits","sequence":"additional","affiliation":[{"name":"1 Szegedi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szent-Gy\u00f6rgyi Albert Klinikai K\u00f6zpont, Seb\u00e9szeti Klinika, Szeged, Semmelweis u. 8., 6720"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"V\u00e1radi","sequence":"additional","affiliation":[{"name":"1 Szegedi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szent-Gy\u00f6rgyi Albert Klinikai K\u00f6zpont, Seb\u00e9szeti Klinika, Szeged, Semmelweis u. 8., 6720"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"Nagy","sequence":"additional","affiliation":[{"name":"2 Szegedi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szent-Gy\u00f6rgyi Albert Klinikai K\u00f6zpont, Radiol\u00f3giai Klinika, Szeged"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endre","family":"Nagy","sequence":"additional","affiliation":[{"name":"2 Szegedi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szent-Gy\u00f6rgyi Albert Klinikai K\u00f6zpont, Radiol\u00f3giai Klinika, Szeged"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Pal\u00e1sthy","sequence":"additional","affiliation":[{"name":"1 Szegedi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Szent-Gy\u00f6rgyi Albert Klinikai K\u00f6zpont, Seb\u00e9szeti Klinika, Szeged, Semmelweis u. 8., 6720"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1 Treat-Jacobson D, McDermott MM, Beckman JA, et al. Implementation of supervised exercise therapy for patients with symptomatic peripheral artery disease: a science advisory from the American Heart Association. Circulation 2019; 140: e700-e710.","DOI":"10.1161\/CIR.0000000000000727"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2 Landi A, Jass\u00f3 I. Peripheral arterial obliterative disease and physical activity. [Arteriosclerosis obliterans \u00e9s fizikai tr\u00e9ning.] Orv Hetil. 2007; 148: 1059-1065. [Hungarian]","DOI":"10.1556\/oh.2007.28141"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3 Jansen SC, Hoorweg BB, Hoeks SE, et al. A systematic review and meta-analysis of the effects of supervised exercise therapy on modifiable cardiovascular risk factors in intermittent claudication. J Vasc Surg. 2019; 69: 1293-1308.e2.","DOI":"10.1016\/j.jvs.2018.10.069"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4 Bedenis R, Stewart M, Cleanthis M, et al. Cilostazol for intermittent claudication. Cochrane Database Syst. Rev. 2014; 2014(10): CD003748.","DOI":"10.1002\/14651858.CD003748.pub4"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5 Farkas K, J\u00e1rai Z, Kolossv\u00e1ry E. Cilostazol is effective and safe option for the treatment of intermittent claudication. Results of the NOCLAUD study. [A cilostazol hat\u00e9kony \u00e9s biztons\u00e1gos lehet\u0151s\u00e9g a claudicatio intermittens kezel\u00e9s\u00e9re. A NOCLAUD vizsg\u00e1lat eredm\u00e9nyei.] Orv Hetil. 2017; 158: 123-128. [Hungarian]","DOI":"10.1556\/650.2017.30660"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6 Farkas K, Kolossv\u00e1ry E, J\u00e1rai Z. Cilostazol improves the quality of life and lower-limb functional capacity also in diabetic patients. [A cilostazol diabeteses betegekben is jav\u00edtja az \u00e9letmin\u0151s\u00e9get \u00e9s az als\u00f3 v\u00e9gtagi funkcion\u00e1lis kapacit\u00e1st.] Orv Hetil. 2020; 161: 1637-1645. [Hungarian]","DOI":"10.1556\/650.2020.31969"},{"key":"ref6","unstructured":"7 Aboyans V, Ricco JB, Bartelink ME, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO). The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018; 39: 763-816."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8 Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007; 45(Suppl): S5-S67.","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"ref8","unstructured":"9 Farkas K, M\u00e1ty\u00e1s L, Pal\u00e1sthy Zs, et al. Profession al guideline of the Hungarian Ministry of Human Capacities for the treatment of peripheral arterial diseases. [Az Emberi Er\u0151forr\u00e1sok Miniszt\u00e9riuma szakmai ir\u00e1nyelve a perif\u00e9ri\u00e1s ver\u0151\u00e9r megbeteged\u00e9sek ell\u00e1t\u00e1s\u00e1r\u00f3l.] E\u00fcK 2017; 3: 650-675. [Hungarian]"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jvs.2009.01.035","article-title":"National trends in lower extremity bypass surgery, endovascular interventions, and major amputation","volume":"50","author":"10 Goodney","year":"2009","unstructured":"10 Goodney PP, Beck AW, Nagle J, et al. National trends in lower extremity bypass surgery, endovascular interventions, and major amputation. J Vasc Surg. 2009; 50: 54-60.","journal-title":"J Vasc Surg"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jvs.2004.02.039","article-title":"Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000","volume":"39","author":"11 Anderson","year":"2004","unstructured":"11 Anderson PL, Gelijns A, Moskowitz A, et al. Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000. J Vasc Surg. 2004; 39: 1200-1208.","journal-title":"J Vasc Surg"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jvs.2015.01.054","article-title":"The future of vascular surgery","volume":"61","author":"12 Schneider","year":"2015","unstructured":"12 Schneider PA. The future of vascular surgery. J Vasc Surg. 2015; 61: 1357-1365.","journal-title":"J Vasc Surg"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13 Veith FJ. A look at the future of vascular surgery. J Vasc Surg. 2016: 64: 885-890.","DOI":"10.1016\/j.jvs.2016.07.096"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14 Bosiers M, Deloose K, Callaert J, et al. Bravissimo: 12-month results from a large scale prospective trial. J Cardiovasc Surg. 2013; 54: 235-253.","DOI":"10.1016\/j.jvs.2012.06.031"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.jvs.2011.02.005","article-title":"Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions","volume":"53","author":"15 Ye","year":"2011","unstructured":"15 Ye W, Liu CW, Ricco JB, et al. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg. 2011; 53: 1728-1737.","journal-title":"J Vasc Surg"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/bjs.9197","article-title":"Randomized clinical trial of stents versus angioplasty for the treatment of iliac artery occlusions (STAG trial)","volume":"100","author":"16 Goode","year":"2013","unstructured":"16 Goode SD, Cleveland TJ, Gaines PA. Randomized clinical trial of stents versus angioplasty for the treatment of iliac artery occlusions (STAG trial). Br J Surg. 2013; 100: 1148-1153.","journal-title":"Br J Surg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1583\/11-3627.1","article-title":"balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial","volume":"19","author":"17 Laird","year":"2012","unstructured":"17 Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther. 2012; 19: 1-9.","journal-title":"J Endovasc Ther"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1161\/CIRCULATIONAHA.107.688341","article-title":"Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting","volume":"115","author":"18 Schillinger","year":"2007","unstructured":"18 Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007; 115: 2745-2749.","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jcin.2013.07.010","article-title":"Drug eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery)","volume":"6","author":"19 Liistro","year":"2013","unstructured":"19 Liistro F, Grotti S, Porto I, et al. Drug eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC Cardiovasc Interv. 2013; 6: 1295-1302.","journal-title":"JACC Cardiovasc Interv"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20 Tepe G, Laird J, Schneider P, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 2015; 131: 495-502.","DOI":"10.1161\/CIRCULATIONAHA.114.011004"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrendo.2011.183","article-title":"The worldwide epidemiology of type 2 diabetes mellitus - present and future perspectives","volume":"8","author":"21 Chen","year":"2012","unstructured":"21 Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus - present and future perspectives. Nat Rev Endocrinol. 2012; 8: 228-236.","journal-title":"Nat Rev Endocrinol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.clindermatol.2004.01.010","article-title":"Obesity: the worldwide epidemic","volume":"22","author":"22 James","year":"2004","unstructured":"22 James PT. Obesity: the worldwide epidemic. Clin Dermatol. 2004; 22: 276-280.","journal-title":"Clin Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23 Salem H, Hasan DM, Eameash A, et al. Worldwide prevalence of hypertension: a pooled meta-analysis of 1670 studies in 71 countries with 29.5 million participants. J Am Coll Cardiol. 2018; 71(11_Suppl): A1819.","DOI":"10.1016\/S0735-1097(18)32360-X"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24 K\u00e9kes E, Barna I, Daiki T, et al. The prevalence of smoking and gender differences according to the data of the national health screening program in 2010-2018 in Hungary. [Nemi k\u00fcl\u00f6nbs\u00e9gek a doh\u00e1nyz\u00e1s gyakoris\u00e1g\u00e1ban haz\u00e1nkban 2010 \u00e9s 2018 k\u00f6z\u00f6tt.] Orv Hetil. 2019; 160: 2047-2053. [Hungarian]","DOI":"10.1556\/650.2019.31637"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1583\/08-2495.1","article-title":"Ionizing radiation in endovascular interventions","volume":"15","author":"25 Walsh","year":"2008","unstructured":"25 Walsh SR, Cousins C, Tang TY, et al. Ionizing radiation in endovascular interventions. J Endovasc Ther. 2008; 15: 680-687.","journal-title":"J Endovasc Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4174\/astr.2017.92.3.156","article-title":"Radiation hazards to vascular surgeon and scrub nurse in mobile fluoroscopy equipped hybrid vascular room","volume":"92","author":"26 Kim","year":"2017","unstructured":"26 Kim JB, Lee J, Prk K. Radiation hazards to vascular surgeon and scrub nurse in mobile fluoroscopy equipped hybrid vascular room. Ann Surg Treat Res. 2017; 92: 156-163.","journal-title":"Ann Surg Treat Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.avsg.2019.04.019","article-title":"Comparison of patient radiation dose and contrast use during EVAR in a dedicated hybrid vascular OR and mobile imaging","volume":"61","author":"27 Rehman","year":"2019","unstructured":"27 Rehman ZU, Choksy S, Howard A, et al. Comparison of patient radiation dose and contrast use during EVAR in a dedicated hybrid vascular OR and mobile imaging. Ann Vasc Surg. 2019; 61: 278-283.","journal-title":"Ann Vasc Surg"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/162\/24\/article-p943.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/162\/24\/article-p943.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T08:53:46Z","timestamp":1698742426000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/162\/24\/article-p943.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,13]]},"references-count":27,"journal-issue":{"issue":"24"},"URL":"https:\/\/doi.org\/10.1556\/650.2021.32099","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,13]]}}}